celecoxib has been researched along with Fibrocartilaginous Dysplasia of Bone in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib is a cyclooxygenase-2 (COX2) inhibitor." | 1.46 | Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects. ( Bhattacharyya, N; Collins, M; Leikin, S; Liu, S; Mertz, EL; Nesterova, M; Saloustros, E; Salpea, P; Starost, MF; Stratakis, CA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saloustros, E | 1 |
| Liu, S | 1 |
| Mertz, EL | 1 |
| Bhattacharyya, N | 1 |
| Starost, MF | 1 |
| Salpea, P | 1 |
| Nesterova, M | 1 |
| Collins, M | 1 |
| Leikin, S | 1 |
| Stratakis, CA | 1 |
1 other study available for celecoxib and Fibrocartilaginous Dysplasia of Bone
| Article | Year |
|---|---|
Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects.
Topics: Animals; Apoptosis; Bone and Bones; Celecoxib; Cell Line; Cell Proliferation; Cyclic AMP-Dependent P | 2017 |